Tag Archives: INGN

Hot Casino Stocks To Own Right Now

Shares of casino operators with ties to Macau were sent lower after news surfaced recently that hotels on the tiny Chinese island of Hainan might begin offering low-stakes baccarat.

Where blackjack and poker are the preferred card games in Western casinos, baccarat is the favorite among China’s VIP gamblers. And because Macau is the only place in China where gaming is legal, some believe that allowing it anywhere else will siphon off high rollers, which will hurt casino companies like Las Vegas Sands (NYSE:LVS), Melco Resorts & Entertainment (NASDAQ:MLCO), and Wynn Resorts (NASDAQ:WYNN), which all derive the bulk of their revenue from Macau.

But the fears look to be overblown because any low-stakes games on Hainan wouldn’t be attractive to the VIPs the casinos count on, and the volume of gaming would likely be a tiny fraction of the $32 billion Macau generated last year.

Sanya City in Dadonghai Bay on Hainan, often called “China’s Hawaii.” Image source: Getty Images.

Hot Casino Stocks To Own Right Now: Inogen, Inc(INGN)

Advisors’ Opinion:

  • [By Joseph Griffin]

    Inogen Inc (NASDAQ:INGN) Director Raymond Huggenberger sold 10,593 shares of the stock in a transaction that occurred on Monday, July 16th. The shares were sold at an average price of $194.51, for a total value of $2,060,444.43. Following the completion of the sale, the director now directly owns 8,890 shares of the company’s stock, valued at $1,729,193.90. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website.

  • [By Logan Wallace]

    Inogen (NASDAQ:INGN) had its price objective upped by investment analysts at Piper Jaffray Companies to $245.00 in a report issued on Tuesday, The Fly reports. The brokerage currently has an “overweight” rating on the medical technology company’s stock. Piper Jaffray Companies’ target price points to a potential upside of 6.48% from the company’s current price.

  • [By Jon C. Ogg]

    Inogen Inc. (NASDAQ: INGN) was downgraded to Buy from Strong Buy at Needham.

    Neurocrine Biosciences Inc. (NASDAQ: NBIX) was started as Overweight and assigned a $145 target price (versus a $116.93 close) at Morgan Stanley.

  • [By Logan Wallace]

    Inogen Inc (NASDAQ:INGN) EVP Byron Myers sold 1,846 shares of the business’s stock in a transaction dated Monday, June 18th. The stock was sold at an average price of $190.04, for a total transaction of $350,813.84. Following the sale, the executive vice president now owns 39,121 shares in the company, valued at $7,434,554.84. The transaction was disclosed in a legal filing with the SEC, which is available at this link.

  • [By Shane Hupp]

    Here are some of the news articles that may have impacted Accern Sentiment’s analysis:

    Get Inogen alerts:

    Comparing Halyard Health (HYH) and Inogen (INGN) (americanbankingnews.com) ‘The stock market has sucked on nitrous oxide’ — Wall… (beaumontenterprise.com) EPS Calculations to Consider – Inogen Inc (NASDAQ: INGN) (stocksmarketcap.com) Inogen’s shares drop on short seller Citron’s tweet (reuters.com) Inogen Hit By Citron Report; Analyst Rebuttal Calls This ‘An Excellent Entry Point’ (msn.com)

    Several equities analysts recently issued reports on the company. JPMorgan Chase & Co. raised their price target on Inogen from $150.00 to $180.00 and gave the stock an “overweight” rating in a research report on Tuesday, May 1st. Leerink Swann restated an “outperform” rating and set a $170.00 price target (up from $150.00) on shares of Inogen in a research report on Tuesday, May 1st. ValuEngine upgraded Inogen from a “buy” rating to a “strong-buy” rating in a research report on Wednesday, May 2nd. Zacks Investment Research upgraded Inogen from a “hold” rating to a “buy” rating and set a $131.00 price target on the stock in a research report on Tuesday, February 13th. Finally, BidaskClub upgraded Inogen from a “hold” rating to a “buy” rating in a research report on Friday, March 9th. One equities research analyst has rated the stock with a hold rating, three have given a buy rating and three have issued a strong buy rating to the company. Inogen has an average rating of “Buy” and an average target price of $178.00.

  • [By Shane Hupp]

    Get a free copy of the Zacks research report on Inogen (INGN)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Hot Casino Stocks To Own Right Now: Baytex Energy Corp(BTE)

Advisors’ Opinion:

  • [By Ethan Ryder]

    Baytex Energy (TSE:BTE) (NYSE:BTE) was upgraded by analysts at CIBC from a neutral rating to an outperform rating.

    Cheniere Energy Partners (NYSEAMERICAN:CQP) was downgraded by analysts at US Capital Advisors to a hold rating. US Capital Advisors currently has $40.00 target price on the stock, up from their previous target price of $35.00.

  • [By Ethan Ryder]

    Get a free copy of the Zacks research report on Baytex Energy (BTE)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Max Byerly]

    Baytex Energy (NYSE: BTE) and Pioneer Energy Services (NYSE:PES) are both small-cap oils/energy companies, but which is the better stock? We will compare the two businesses based on the strength of their institutional ownership, analyst recommendations, profitability, earnings, valuation, risk and dividends.

  • [By Joseph Griffin]

    BitSerial (CURRENCY:BTE) traded 16.5% lower against the U.S. dollar during the twenty-four hour period ending at 18:00 PM Eastern on September 7th. One BitSerial token can currently be bought for $0.0030 or 0.00000046 BTC on popular cryptocurrency exchanges. BitSerial has a total market cap of $0.00 and $73.00 worth of BitSerial was traded on exchanges in the last day. Over the last seven days, BitSerial has traded 8.3% lower against the U.S. dollar.

Hot Casino Stocks To Own Right Now: Ultragenyx Pharmaceutical Inc.(RARE)

Advisors’ Opinion:

  • [By Shane Hupp]

    These are some of the media headlines that may have effected Accern’s scoring:

    Get Ultragenyx Pharmaceutical alerts:

    Burosumab Improves Outcomes in Children with XLH in Phase 2 Trial (raredr.com) RARE Stock Is on the Verge of Breaking Out Toward Higher Prices (profitconfidential.com) Burosumab may benefit children with X-linked hypophosphatemia (medicalxpress.com) A Look Inside the Quant Data For Ultragenyx Pharmaceutical Inc. (NasdaqGS:RARE) (parkcitycaller.com) Ultragenyx Pharmaceutical Inc. (RARE)- Stock in the Trader’s Radar (nasdaqfortune.com)

    A number of research firms have recently weighed in on RARE. ValuEngine raised Ultragenyx Pharmaceutical from a “hold” rating to a “buy” rating in a report on Saturday. BidaskClub raised Ultragenyx Pharmaceutical from a “buy” rating to a “strong-buy” rating in a report on Saturday, May 19th. Barclays raised Ultragenyx Pharmaceutical from an “equal weight” rating to an “overweight” rating and lifted their target price for the stock from $62.00 to $74.00 in a report on Friday, May 11th. Goldman Sachs Group began coverage on Ultragenyx Pharmaceutical in a report on Thursday, May 10th. They set a “neutral” rating and a $63.00 target price for the company. Finally, Zacks Investment Research downgraded Ultragenyx Pharmaceutical from a “hold” rating to a “sell” rating in a report on Tuesday, January 30th. One research analyst has rated the stock with a sell rating, four have issued a hold rating, seventeen have given a buy rating and one has given a strong buy rating to the stock. The company has an average rating of “Buy” and a consensus target price of $70.06.

  • [By Chris Lange]

    Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) is expected to report Phase 2 data from all its tumor-induced osteomalacia patients. Shares of Ultragenyx closed Friday at $76.87, in a 52-week range of $41.67 to $86.10 and with a consensus analyst target of $68.74.

  • [By Shane Hupp]

    Get a free copy of the Zacks research report on Ultragenyx Pharmaceutical (RARE)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top Energy Stocks To Invest In 2019

Money Morning Defense and Tech Specialist Michael Robinson believes the prices of marijuana stocks are about to soar.

And when Robinson talks about the cannabis market, we listen…

Michael’s been a giant in investing for more than 30 years. As a leading analyst and tech journalist, he’s been on the forefront of just about every major emerging technology story of the last decade.

He’s even been nominated for a Pulitzer Prize.

His privileged access to technology-pioneering CEOs… prize-winning scientists… and high-profile industry insiders has allowed him to consistently give investors huge gains on remarkable breakthroughs, like 3D printing, the mobile wave, and shale energy technologies, well before anyone else.

Top Energy Stocks To Invest In 2019: Inogen, Inc(INGN)

Advisors’ Opinion:

  • [By Logan Wallace]

    Rock Springs Capital Management LP lifted its stake in shares of Inogen Inc (NASDAQ:INGN) by 38.1% during the first quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 110,500 shares of the medical technology company’s stock after purchasing an additional 30,500 shares during the quarter. Rock Springs Capital Management LP owned 0.52% of Inogen worth $13,574,000 as of its most recent SEC filing.

  • [By Shane Hupp]

    Here are some of the news articles that may have impacted Accern Sentiment’s analysis:

    Get Inogen alerts:

    Comparing Halyard Health (HYH) and Inogen (INGN) (americanbankingnews.com) ‘The stock market has sucked on nitrous oxide’ Wall… (beaumontenterprise.com) EPS Calculations to Consider Inogen Inc (NASDAQ: INGN) (stocksmarketcap.com) Inogen’s shares drop on short seller Citron’s tweet (reuters.com) Inogen Hit By Citron Report; Analyst Rebuttal Calls This ‘An Excellent Entry Point’ (msn.com)

    Several equities analysts recently issued reports on the company. JPMorgan Chase & Co. raised their price target on Inogen from $150.00 to $180.00 and gave the stock an “overweight” rating in a research report on Tuesday, May 1st. Leerink Swann restated an “outperform” rating and set a $170.00 price target (up from $150.00) on shares of Inogen in a research report on Tuesday, May 1st. ValuEngine upgraded Inogen from a “buy” rating to a “strong-buy” rating in a research report on Wednesday, May 2nd. Zacks Investment Research upgraded Inogen from a “hold” rating to a “buy” rating and set a $131.00 price target on the stock in a research report on Tuesday, February 13th. Finally, BidaskClub upgraded Inogen from a “hold” rating to a “buy” rating in a research report on Friday, March 9th. One equities research analyst has rated the stock with a hold rating, three have given a buy rating and three have issued a strong buy rating to the company. Inogen has an average rating of “Buy” and an average target price of $178.00.

  • [By Logan Wallace]

    Inogen Inc (NASDAQ:INGN) EVP Byron Myers sold 1,846 shares of the business’s stock in a transaction dated Monday, June 18th. The stock was sold at an average price of $190.04, for a total transaction of $350,813.84. Following the sale, the executive vice president now owns 39,121 shares in the company, valued at $7,434,554.84. The transaction was disclosed in a legal filing with the SEC, which is available at this link.

Top Energy Stocks To Invest In 2019: Credicorp Ltd.(BAP)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Credicorp (NYSE: BAP) and Opus Bank (NASDAQ:OPB) are both finance companies, but which is the superior investment? We will contrast the two businesses based on the strength of their analyst recommendations, valuation, profitability, dividends, institutional ownership, risk and earnings.

  • [By Max Byerly]

    CI Investments Inc. reduced its holdings in shares of Credicorp Ltd. (NYSE:BAP) by 85.3% during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 23,420 shares of the bank’s stock after selling 136,150 shares during the quarter. CI Investments Inc.’s holdings in Credicorp were worth $5,317,000 at the end of the most recent quarter.

  • [By Ethan Ryder]

    News headlines about Credicorp (NYSE:BAP) have trended somewhat positive this week, according to Accern Sentiment. The research group rates the sentiment of press coverage by analyzing more than 20 million news and blog sources. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Credicorp earned a media sentiment score of 0.16 on Accern’s scale. Accern also gave news coverage about the bank an impact score of 46.1243031785915 out of 100, meaning that recent press coverage is somewhat unlikely to have an effect on the stock’s share price in the next few days.

Top Energy Stocks To Invest In 2019: Hawaiian Telcom Holdco, Inc.(HCOM)

Advisors’ Opinion:

  • [By Max Byerly]

    News coverage about Hawaiian Telcom HoldCo (NASDAQ:HCOM) has been trending somewhat positive recently, according to Accern Sentiment Analysis. The research group identifies positive and negative news coverage by monitoring more than 20 million news and blog sources in real time. Accern ranks coverage of publicly-traded companies on a scale of negative one to one, with scores nearest to one being the most favorable. Hawaiian Telcom HoldCo earned a news impact score of 0.06 on Accern’s scale. Accern also assigned media coverage about the utilities provider an impact score of 46.776618457707 out of 100, meaning that recent news coverage is somewhat unlikely to have an effect on the company’s share price in the near future.

Hot Undervalued Stocks To Buy Right Now

According to the GuruFocus All-in-One Screener, several gurus are focusing on stocks whose Peter Lynch fair values are far above the current prices. The following stocks are trading with wide margins of safety and have positive performances over the past 12 months.

Navigator Holdings Ltd. (NVGS) is trading around $11 per share. The Peter Lynch value gives the stock a fair price of $27.5 so the stock is undervalued with a margin of safety of 59%. Twelve weeks back the stock started its positive upward trend; it now registers a positive performance of 35.8%.

The company owns and operates a fleet of handy-sized liquefied gas carriers. It provides seaborne transportation services of liquefied petroleum gas, petrochemical gases and ammonia for energy companies, industrial users and commodity traders.

The stock is trading with a price-earnings (P/E) ratio of 10.00, which is higher than 73% of companies in the Global Shipping & Ports industry. The price is 37.75% below its 52-week high and 70.02% above its 52-week low. The price-book (P/B) ratio is 0.64.

Hot Undervalued Stocks To Buy Right Now: Host Hotels & Resorts, Inc.(HST)

Advisors’ Opinion:

  • [By Max Byerly]

    ING Groep NV increased its stake in shares of Host Hotels & Resorts (NYSE:HST) by 6.6% during the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 75,007 shares of the real estate investment trust’s stock after buying an additional 4,642 shares during the quarter. ING Groep NV’s holdings in Host Hotels & Resorts were worth $1,398,000 at the end of the most recent reporting period.

  • [By Shane Hupp]

    Get a free copy of the Zacks research report on Host Hotels & Resorts (HST)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on Host Hotels & Resorts (HST)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Logan Wallace]

    Host Hotels & Resorts (NYSE:HST) had its price objective boosted by Stifel Nicolaus from $20.50 to $21.00 in a research note published on Thursday. They currently have a buy rating on the real estate investment trust’s stock.

  • [By ]

    Selected examples: (BXP) , (DFS) , (HST) , (MA) , (TXN) , (USB) .

    Inflation Is a Key Risk

    Execs were most worried about inflation, as they should be.

Hot Undervalued Stocks To Buy Right Now: Inogen, Inc(INGN)

Advisors’ Opinion:

  • [By Shane Hupp]

    Here are some of the news articles that may have impacted Accern Sentiment’s analysis:

    Get Inogen alerts:

    Comparing Halyard Health (HYH) and Inogen (INGN) (americanbankingnews.com) ‘The stock market has sucked on nitrous oxide’ Wall… (beaumontenterprise.com) EPS Calculations to Consider Inogen Inc (NASDAQ: INGN) (stocksmarketcap.com) Inogen’s shares drop on short seller Citron’s tweet (reuters.com) Inogen Hit By Citron Report; Analyst Rebuttal Calls This ‘An Excellent Entry Point’ (msn.com)

    Several equities analysts recently issued reports on the company. JPMorgan Chase & Co. raised their price target on Inogen from $150.00 to $180.00 and gave the stock an “overweight” rating in a research report on Tuesday, May 1st. Leerink Swann restated an “outperform” rating and set a $170.00 price target (up from $150.00) on shares of Inogen in a research report on Tuesday, May 1st. ValuEngine upgraded Inogen from a “buy” rating to a “strong-buy” rating in a research report on Wednesday, May 2nd. Zacks Investment Research upgraded Inogen from a “hold” rating to a “buy” rating and set a $131.00 price target on the stock in a research report on Tuesday, February 13th. Finally, BidaskClub upgraded Inogen from a “hold” rating to a “buy” rating in a research report on Friday, March 9th. One equities research analyst has rated the stock with a hold rating, three have given a buy rating and three have issued a strong buy rating to the company. Inogen has an average rating of “Buy” and an average target price of $178.00.

Hot Undervalued Stocks To Buy Right Now: Encore Wire Corporation(WIRE)

Advisors’ Opinion:

  • [By Logan Wallace]

    Encore Wire (NASDAQ: WIRE) and Arconic (NYSE:ARNC) are both industrial products companies, but which is the better business? We will contrast the two businesses based on the strength of their institutional ownership, valuation, analyst recommendations, profitability, dividends, earnings and risk.

Hot Undervalued Stocks To Buy Right Now: Carbonite, Inc.(CARB)

Advisors’ Opinion:

  • [By Jon C. Ogg]

    Carbonite Inc. (NASDAQ: CARB) was reiterated as Outperform and the price target was raised to $35 from $30 at Oppenheimer.

    Carrizo Oil & Gas Inc. (NASDAQ: CRZO) was maintained as Buy but the price target was cut to $44 from $45 at Stifel.

  • [By Shane Hupp]

    Get a free copy of the Zacks research report on Carbonite (CARB)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Stephan Byrd]

    Carbonite (NASDAQ:CARB) was upgraded by equities researchers at BidaskClub from a “buy” rating to a “strong-buy” rating in a note issued to investors on Thursday.

Hot Undervalued Stocks To Buy Right Now: J.B. Hunt Transport Services Inc.(JBHT)

Advisors’ Opinion:

  • [By Chris Lange]

    The stock posting the largest daily percentage gain in the S&P 500 ahead of the close Monday was J.B. Hunt Transport Services, Inc. (NASDAQ: JBHT) which rose about 6% to $119.64. The stocks 52-week range is $83.35 to $126.49. Volume was over 2 million compared to the daily average volume of 1 million.

  • [By Garrett Baldwin]

    The ongoing trade rift between the United States and China continues to plague international markets. Despite reports that both countries are working behind the scenes to prevent additional detrimental trade policies, both countries recently proposed tens of billions in new tariffs on one another. The United States has accused China of widespread intellectual property theft, while China has accused the United States of unfair trade practices, including price manipulation in the agricultural industry. This morning, it’s worth noting that proposed tariffs on U.S. business jets will likely not provide a competitive advantage to foreign competition. Reuters reports that Chinese aviation executives do not see the layer of protectionism as a way to bolster the nation’s local market. Check back to Money Morning today for more insight on how the ongoing trade war could affect your investments.
    Finally, investors will continue to monitor ongoing developments in Washington around the presidency of Donald Trump. The White House has asked a federal judge to block prosecutors from reviewing any files seized from his lawyer’s office during a raid by the FBI last week. The agency seized a trove of documents from lawyer Michael Cohen’s office as part of an investigation into a payment of hush money. The spat between the White House and the FBI continues a day after former FBI Director James Comey called Trump “morally unfit to be president.”
    Three Stocks to Watch Today: BAC, NFLX, AAPL
    Shares of Bank of America Corp. (NYSE: BAC) added nearly 1% after the nation’s largest bank by deposits topped Wall Street earning expectations. The financial institution leads a busy day of earnings reports on Wall Street and hopes to keep its positive momentum from previous quarters. The firm reported earnings per share of $0.62 on top of $23.27 billion in revenue. That topped expectations of $0.59 on top of $22.91 billion thanks to strong growth in its consumer loan business and the r

  • [By ]

    JB Hunt Transport Services (Nasdaq: JBHT) specializes in the truck-to-rail intermodal segment of the industry, which means it may not benefit quite as much as the long-haul operators. Wages as a percentage of revenue are the lowest among the four competitors surveyed, though the average driver salary is slightly above the industry average.

  • [By ]

    But then there’s the little-known trucking company JB Hunt (JBHT) , which popped 6.1% because the company saw some surprise growth that no one was expecting. That news was so strong, FedEx (FDX) and XPO Logistics (XPO) also rose 2.2% and 4.6%.

  • [By ]

    In the Lightning Round, Cramer was bullish on T-Mobile US (TMUS) , Lennar (LEN) , Toll Brothers (TOL) , Tyson Foods (TSN) , JB Hunt Transport Services (JBHT) and International Paper (IP) .

Hot Undervalued Stocks To Buy Right Now: TC PipeLines, LP(TCP)

Advisors’ Opinion:

  • [By Lisa Levin] Gainers
    Shineco, Inc. (NASDAQ: TYHT) rose 34.7 percent to $2.29 in pre-market trading following Q3 results. Shineco posted Q3 earnings of $0.21 per share on sales of $13.3 million.
    Carver Bancorp, Inc. (NASDAQ: CARV) rose 15.8 percent to $12.74 in pre-market trading after surging 201.37 percent on Thursday.
    LiveXLive Media, Inc. (NASDAQ: LIVX) shares rose 11.5 percent to $7.75 in pre-market trading after climbing 64.50 percent on Thursday.
    Eiger BioPharmaceuticals, Inc. (NASDAQ: EIGR) rose 9 percent to $18.30 in pre-market trading after climbing 41.77 percent on Thursday.
    AmTrust Financial Services Inc (NASDAQ: AFSI) rose 6.2 percent to $14.25 in pre-market trading after a 13D filing from Carl Icahn shows a new 9.38 percent stake in the company. The filing also shows language from Icahn that strongly opposes a go-private transaction.
    Cerner Corporation (NASDAQ: CERN) rose 5.6 percent to $64.02 in pre-market trading after the Department of Veterans Affairs reported an agreement with Cerner Government Services, Inc. to provide seamless care for veterans.
    PetroChina Company Limited (NYSE: PTR) shares rose 5.3 percent to $82.05 in pre-market trading.
    TC PipeLines, LP (NYSE: TCP) shares rose 5.2 percent to $26.59 in the pre-market trading session.
    IQVIA Holdings Inc. (NYSE: IQV) shares rose 4.8 percent to $102.50 in pre-market trading as the company pulled secondary offering 'in light of recent market conditions'.
    Axon Enterprise, Inc. (NASDAQ: AAXN) rose 4.5 percent to $59.70 in pre-market trading. On Thursday, Axon priced its 4.3 million share offering of common stock at $53 per share.
    The Trade Desk, Inc. (NASDAQ: TTD) rose 4.5 percent to $84 in pre-market trading.
    PetIQ Inc (NASDAQ: PETQ) rose 3.9 percent to $18.96 in pre-market trading after a 13G filing shows a new 5.05 percent stake by the State of New Jersey's Division of Investment.
    Mattel, Inc. (NASDAQ: MAT) shares rose 3.7 percent to $15.85 in pre-market
  • [By Lisa Levin] Gainers
    Integrated Media Technology Limited (NASDAQ: IMTE) rose 30.8 percent to $22.00 in pre-market trading after declining 18.63 percent on Monday.
    Nevsun Resources Ltd. (NYSE: NSU) rose 14.5 percent to $3.40 in pre-market trading after Lundin Mining Corporation and Euro Sun Mining Inc. proposed to acquire Nevsun Resources for around C$1.5 billion.
    Sharing Economy International Inc. (NASDAQ: SEII) rose 15.2 percent to $4.25 in pre-market trading after the company disclosed that it entered into a license agreement with Ecrent Capital Holdings Limited.
    Veeco Instruments Inc. (NASDAQ: VECO) shares rose 14.1 percent to $19.50 in pre-market trading after reporting stronger-than-expected earnings for its first quarter.
    Impinj, Inc. (NASDAQ: PI) rose 13.4 percent to $15.40 in pre-market trading after reporting Q1 results.
    SandRidge Energy, Inc. (NYSE: SD) shares rose 13.2 percent to $16.45 in pre-market trading following Q1 results.
    Blink Charging Co. (NASDAQ: BLNK) rose 12.6 percent to $4.55 in pre-market trading after jumping 171.14 percent on Monday.
    Crocs, Inc. (NASDAQ: CROX) shares rose 10 percent to $16.66 in pre-market trading after the company reported better-than-expected earnings for its first quarter and issued strong sales forecast for the second quarter.
    Pareteum Corporation (NASDAQ: TEUM) rose 9.7 percent to $3.05 in pre-market trading after announcing Q1 results.
    Dean Foods Company (NYSE: DF) rose 8 percent to $9.00 in pre-market trading after reporting upbeat Q1 earnings.
    Fiesta Restaurant Group, Inc. (NASDAQ: FRGI) rose 7.3 percent to $23.45 in pre-market trading following Q1 results.
    IAMGOLD Corporation (NYSE: IAG) rose 7.1 percent to $6.09 in pre-market trading after reporting upbeat Q1 earnings.
    TC PipeLines, LP (NYSE: TCP) rose 6.4 percent to $27 in pre-market trading after gaining 2.08 percent on Monday.
    Carrols Restaurant Group, Inc. (NASDAQ: TAST) rose 6.3 percent to $11.75 in pre-market trading fol
  • [By Matthew DiLallo]

    Most investors have probably heard of energy giants Royal Dutch Shell (NYSE:RDS-A) (NYSE:RDS-B), Dominion Energy (NYSE:D), and TransCanada (NYSE:TRP). Fewer, however, are likely familiar with their publicly traded master limited partnerships (MLPs): Shell Midstream Partners (NYSE:SHLX), Dominion Energy Midstream Partners (NYSE:DM), and TC Pipelines (NYSE:TCP). That might be a good thing, as the market has beaten up the latter trio this year, sending their valuations south.

Top 10 Safest Stocks For 2019

Every night in 1995, I would deposit money overnight in a different currency…   Sounds strange, I realize.   But back then, as the vice president of a global mutual fund, one of my jobs was to execute our fund's trades.   Once our U.S. trading day was done, we wanted our money to work for us overnight as well. We might put our money into French francs, German marks, or somewhere else – just for the night.   We would find the safest country that was paying the highest interest rate. And we would put our money there overnight. No kidding.   As I'll explain today, what we were doing wasn't anything special…   Big companies like German automaker Volkswagen and Japanese automaker Honda (and thousands of other companies) have cash-management departments that do basically the same thing – on a much larger scale.

Top 10 Safest Stocks For 2019: Netlist, Inc.(NLST)

Advisors’ Opinion:

  • [By Shane Hupp]

    Netlist (NASDAQ:NLST)’s share price gapped up before the market opened on Wednesday . The stock had previously closed at $0.10, but opened at $0.14. Netlist shares last traded at $0.16, with a volume of 5420 shares.

  • [By Shane Hupp]

    These are some of the news headlines that may have impacted Accern’s scoring:

    Get Acacia Research alerts:

    Thrashing Stocks: Netlist, Inc. (NASDAQ:NLST), Vitamin Shoppe, Inc. (NYSE:VSI), Acacia Research Corporation … (thestreetpoint.com) Form DEFA14A ACACIA RESEARCH CORP (streetinsider.com) Acacia Research Corporation Board of Directors Issues Letter to Stockholders (markets.financialcontent.com) Have a sight on these: Yamana Gold Inc. (NYSE:AUY), Acacia Research Corporation (NASDAQ:ACTG), Navios … (journalfinance.net) Stocks in the Spotlight: Gold Fields Limited (NYSE:GFI), Acacia Research Corporation (NASDAQ:ACTG), China … (journalfinance.net)

    Several equities analysts have recently weighed in on ACTG shares. Zacks Investment Research downgraded shares of Acacia Research from a “buy” rating to a “hold” rating in a research note on Friday, March 23rd. ValuEngine downgraded shares of Acacia Research from a “buy” rating to a “hold” rating in a research note on Wednesday, May 2nd. Finally, TheStreet downgraded shares of Acacia Research from a “c-” rating to a “d” rating in a research note on Friday, February 16th. Two analysts have rated the stock with a sell rating, one has assigned a hold rating and one has assigned a buy rating to the company. The stock currently has a consensus rating of “Hold” and an average price target of $5.67.

Top 10 Safest Stocks For 2019: Becton, Dickinson and Company(BDX)

Advisors’ Opinion:

  • [By Brian Orelli]

    Becton, Dickinson (NYSE:BDX) reported wacky results for its second fiscal quarter.This is the first quarter that the medical supply company has included results from itsacquisitionofC.R. Bard. But looking at the two companies on a comparable basis, it was a solid quarter for the newly combined company.

  • [By Keith Speights]

    Dividend Yield

    Abbott Laboratories (NYSE:ABT) Drugs $109 billion 19.37 1.88%
    AstraZeneca (NYSE: AZN) Drugs $93 billion 19.70 3.97%
    Becton Dickinson and Co. (NYSE: BDX) Medical supplies $60 billion 17.74 1.29%
    DexCom (NASDAQ: DXCM) Medical devices $8 billion N/A N/A
    Eli Lilly and Co. (NYSE: LLY) Drugs $85 billion 14.91 2.77%
    Insulet (NASDAQ: PODD) Medical devices $5 billion 273.03 N/A
    Johnson & Johnson (NYSE: JNJ) Drugs, medical devices $325 billion 14.16 2.57%
    Lexicon Pharmaceuticals (NASDAQ:LXRX) Drugs $1 billion N/A N/A
    MannKind (NASDAQ: MNKD) Drugs $270 million N/A N/A
    Medtronic (NYSE: MDT) Medical devices $117 billion 15.36 2.14%
    Merck & Co. (NYSE: MRK) Drugs $159 billion 12.99 3.22%
    Novo Nordisk (NYSE:NVO) Drugs $116 billion 18.29 2.61%
    Pfizer (NYSE: PFE) Drugs $209 billion 11.62 3.82%
    Regeneron Pharmaceuticals (NASDAQ: REGN) Drugs $32 billion 13.95 N/A
    Sanofi (NYSE: SNY) Drugs $95 billion 10.75 4.64%
    Senseonics Holdings (NYSEMKT: SENS) Medical devices $447 million N/A N/A
    Tandem Diabetes Care (NASDAQ: TNDM) Medical devices $711 million N/A N/A

    Data source: Yahoo! Finance. P/E = price-to-earnings ratio; N/A = not applicable. Data as of May 25, 2018.

Top 10 Safest Stocks For 2019: Johnson Outdoors Inc.(JOUT)

Advisors’ Opinion:

  • [By Lisa Levin] Companies Reporting Before The Bell
    Celgene Corporation (NASDAQ: CELG) is projected to report quarterly earnings at $1.96 per share on revenue of $3.46 billion.
    Aon plc (NYSE: AON) is expected to report quarterly earnings at $2.8 per share on revenue of $2.93 billion.
    American Axle & Manufacturing Holdings, Inc. (NYSE: AXL) is estimated to report quarterly earnings at $0.81 per share on revenue of $1.75 billion.
    Alibaba Group Holding Limited (NYSE: BABA) is expected to report quarterly earnings at $0.88 per share on revenue of $9.27 billion.
    LifePoint Health, Inc. (NASDAQ: LPNT) is projected to report quarterly earnings at $1.13 per share on revenue of $1.62 billion.
    V.F. Corporation (NYSE: VFC) is estimated to report quarterly earnings at $0.65 per share on revenue of $2.90 billion.
    Newell Brands Inc. (NYSE: NWL) is expected to report quarterly earnings at $0.26 per share on revenue of $3.05 billion.
    Titan International, Inc. (NYSE: TWI) is projected to report quarterly earnings at $0.04 per share on revenue of $407.27 million.
    Boise Cascade Company (NYSE: BCC) is expected to report quarterly earnings at $0.45 per share on revenue of $1.09 billion.
    Cheniere Energy, Inc. (NYSE: LNG) is estimated to report quarterly earnings at $0.39 per share on revenue of $1.59 billion.
    Cboe Global Markets, Inc. (NASDAQ: CBOE) is projected to report quarterly earnings at $1.24 per share on revenue of $308.05 million.
    ITT Inc. (NYSE: ITT) is estimated to report quarterly earnings at $0.73 per share on revenue of $683.96 million.
    Fred's, Inc. (NASDAQ: FRED) is expected to report quarterly loss at $0.19 per share on revenue of $551.00 million.
    Virtu Financial, Inc. (NASDAQ: VIRT) is projected to report quarterly earnings at $0.52 per share on revenue of $288.31 million.
    Cheniere Energy Partners, L.P. (NYSE: CQP) is expected to report quarterly earnings at $0.57 per share on revenue of $1.38 billion.
    Genesis Energy, L.P

Top 10 Safest Stocks For 2019: Meridian Interstate Bancorp Inc.(EBSB)

Advisors’ Opinion:

  • [By Logan Wallace]

    BidaskClub upgraded shares of Meridian Bancorp (NASDAQ:EBSB) from a hold rating to a buy rating in a research report sent to investors on Friday morning.

Top 10 Safest Stocks For 2019: Stewart Information Services Corporation(STC)

Advisors’ Opinion:

  • [By Ethan Ryder]

    StarChain (CURRENCY:STC) traded 8.7% lower against the US dollar during the 24-hour period ending at 20:00 PM E.T. on May 14th. StarChain has a market cap of $0.00 and approximately $5.27 million worth of StarChain was traded on exchanges in the last 24 hours. One StarChain token can now be purchased for about $0.0925 or 0.00001062 BTC on major cryptocurrency exchanges. During the last seven days, StarChain has traded down 16.3% against the US dollar.

  • [By Stephan Byrd]

    Argo Group (NASDAQ: AGII) and Stewart Information Services (NYSE:STC) are both small-cap finance companies, but which is the better business? We will compare the two companies based on the strength of their valuation, risk, earnings, dividends, institutional ownership, profitability and analyst recommendations.

Top 10 Safest Stocks For 2019: Simmons First National Corporation(SFNC)

Advisors’ Opinion:

  • [By Logan Wallace]

    Simmons First National Co. (NASDAQ:SFNC) reached a new 52-week high and low during trading on Friday . The stock traded as low as $31.10 and last traded at $30.80, with a volume of 3453 shares traded. The stock had previously closed at $30.95.

Top 10 Safest Stocks For 2019: Inogen, Inc(INGN)

Advisors’ Opinion:

  • [By Shane Hupp]

    Here are some of the news articles that may have impacted Accern Sentiment’s analysis:

    Get Inogen alerts:

    Comparing Halyard Health (HYH) and Inogen (INGN) (americanbankingnews.com) ‘The stock market has sucked on nitrous oxide’ Wall… (beaumontenterprise.com) EPS Calculations to Consider Inogen Inc (NASDAQ: INGN) (stocksmarketcap.com) Inogen’s shares drop on short seller Citron’s tweet (reuters.com) Inogen Hit By Citron Report; Analyst Rebuttal Calls This ‘An Excellent Entry Point’ (msn.com)

    Several equities analysts recently issued reports on the company. JPMorgan Chase & Co. raised their price target on Inogen from $150.00 to $180.00 and gave the stock an “overweight” rating in a research report on Tuesday, May 1st. Leerink Swann restated an “outperform” rating and set a $170.00 price target (up from $150.00) on shares of Inogen in a research report on Tuesday, May 1st. ValuEngine upgraded Inogen from a “buy” rating to a “strong-buy” rating in a research report on Wednesday, May 2nd. Zacks Investment Research upgraded Inogen from a “hold” rating to a “buy” rating and set a $131.00 price target on the stock in a research report on Tuesday, February 13th. Finally, BidaskClub upgraded Inogen from a “hold” rating to a “buy” rating in a research report on Friday, March 9th. One equities research analyst has rated the stock with a hold rating, three have given a buy rating and three have issued a strong buy rating to the company. Inogen has an average rating of “Buy” and an average target price of $178.00.

Top 10 Safest Stocks For 2019: Aerosonic Corporation(AIM)

Advisors’ Opinion:

  • [By Shane Hupp]

    Aimia (TSE:AIM) has earned an average rating of “Hold” from the seven research firms that are currently covering the company, MarketBeat.com reports. Two equities research analysts have rated the stock with a sell recommendation, four have assigned a hold recommendation and one has given a buy recommendation to the company. The average 1-year price target among analysts that have issued a report on the stock in the last year is C$2.67.

Top 10 Safest Stocks For 2019: Mosaic Company (MOS)

Advisors’ Opinion:

  • [By Joseph Griffin]

    The Mosaic (NYSE:MOS) issued its quarterly earnings data on Monday. The basic materials company reported $0.20 earnings per share (EPS) for the quarter, missing the Thomson Reuters’ consensus estimate of $0.28 by ($0.08), Bloomberg Earnings reports. The Mosaic had a negative net margin of 1.45% and a positive return on equity of 3.90%. The firm had revenue of $1.93 billion during the quarter, compared to analyst estimates of $1.85 billion. During the same period last year, the business earned $0.04 EPS. The firm’s revenue was up 22.5% compared to the same quarter last year. The Mosaic updated its FY18 guidance to $1.20-1.60 EPS.

  • [By Shane Hupp]

    Swiss National Bank cut its stake in The Mosaic Company (NYSE:MOS) by 13.2% during the 1st quarter, according to its most recent Form 13F filing with the SEC. The fund owned 1,066,065 shares of the basic materials company’s stock after selling 162,000 shares during the period. Swiss National Bank owned approximately 0.30% of The Mosaic worth $25,884,000 as of its most recent SEC filing.

  • [By Stephan Byrd]

    The Mosaic Company (NYSE:MOS) has been assigned an average rating of “Hold” from the nineteen brokerages that are covering the company, MarketBeat reports. Four equities research analysts have rated the stock with a sell recommendation, ten have given a hold recommendation and five have given a buy recommendation to the company. The average 12-month target price among brokerages that have covered the stock in the last year is $25.23.

  • [By Garrett Baldwin]

    Oil prices are at levels we haven’t seen in years. U.S. crude topped $70 for the first since 2014, as U.S. President Donald Trump appeared increasingly likely to pull out of the Iran nuclear deal and reinforce sanctions on Tehran. In addition, OPEC has announced plans to bolster prices and cap production. For oil investors, Money MorningGlobal Energy Strategist Dr. Kent Moors says it’s time to buckle up. According to Moors, revoking the Iran deal would cause “price chaos” around the globe. And that’s right as driving season starts in the United States. Here’s more on the coming chaos for oil. In deal news, Blackstone Group (NYSE: BX) announced it will purchase Gramercy Property Trust (NYSE: GPT) for $7.6 billion in cash. Grammercy manages commercial real estate. While this may seem like a boring deal, Blackstone is buying a business that churns out cold hard cash for its investors. We want to keep this deal on your radar, because there are many other deals like this coming down the pipeline. We’re going to be discussing one of the best real estate opportunities available very soon – so keep an eye out for updates.
    Three Stocks to Watch Today: AMZN, AAPL, TSN, SBUX
    Shareholders of Amazon.com Inc. (Nasdaq: AMZN) cheered statements made by Warren Buffett over the weekend. The Oracle of Omaha said he messed up by not investing in Amazon and Alphabet Inc. (Nasdaq: GOOGL). “I made the wrong decisions on Google and Amazon,” Buffett said on Saturday. “We’ve looked at it. I made the mistake in not being able to come to a conclusion where I really felt that at the present prices that the prospects were far better than the prices indicated.” Buffett says he now has a “very, very, very high opinion” of Amazon CEO Jeff Bezos. The Oracle believes that Bezos has created something that is “close to a miracle.” Apple Inc. (Nasdaq: AAPL) added another 0.6% Monday, to reach $185.00 per share – a new 52-week high. The uptick came after Warren Buffett announced

  • [By ]

    HSBC’s top stocks list is mostly dominated by large-cap plays that happen to pay attractive dividend yields. More importantly, the stocks already have a decent amount of momentum behind them: the average one-month performance is +5.5%. 

    Baker Hughes (BHGE) Tiffany & Co. (TIF) The Mosaic Company (MOS) Deutsche Telekom Schneider Electric Adidas (ADDYY) Unicredit  CRH (CRH) Luftansa  GlaxosmithKline (GSK) Associated British Foods   Fresnillo China Construction Bank China Overseas Land & Inv. Geely Automobile Holdings CRCC China Resources Beer Samsung Electronic Sasol Adani Ports and SEZ

Top 10 Safest Stocks For 2019: Unilever PLC(UL)

Advisors’ Opinion:

  • [By Lisa Levin]

    Check out these big penny stock gainers and losers

    Losers
    Aceto Corporation (NASDAQ: ACET) fell 41.9 percent to $4.30 in pre-market trading. ACETO board disclosed that it is taking proactive steps to address business and financial challenges. Canaccord Genuity downgraded Aceto from Buy to Sell.
    Helios and Matheson Analytics Inc. (NASDAQ: HMNY) fell 25.3 percent to $2.86 in pre-market trading after reporting an ATM offering of $150 million.
    Pier 1 Imports, Inc. (NYSE: PIR) fell 17.4 percent to $2.86 in pre-market trading after reporting a fourth quarter sales miss. Comps were down 7.5 percent in the quarter.
    Sleep Number Corporation (NASDAQ: SNBR) fell 12.4 percent to $32.00 in pre-market trading following a first quarter earnings miss.
    Paratek Pharmaceuticals, Inc. (NASDAQ: PRTK) fell 10.2 percent to $11.90 in pre-market trading on news of $125 million convertible debt offering.
    Merrimack Pharmaceuticals, Inc. (NASDAQ: MACK) shares fell 8 percent to $8.02 in pre-market trading after dropping 2.02 percent on Wednesday.
    Exponent, Inc. (NASDAQ: EXPO) shares fell 5.6 percent to $80 in pre-market trading.
    Lumentum Holdings Inc. (NASDAQ: LITE) shares fell 4.8 percent to $60.00 in pre-market trading after rising 1.78 percent on Wednesday.
    vTv Therapeutics Inc. (NASDAQ: VTVT) fell 4.6 percent to $2.10 in pre-market trading after surging 84.87 percent on Wednesday.
    Taiwan Semiconductor Manufacturing Company Limited (NYSE: TSM) shares fell 4.5 percent to $40.07 in pre-market trading after the company reported Q1 results.
    Align Technology, Inc.. (NASDAQ: ALGN) fell 3.5 percent to $267.40 in pre-market trading after rising 1.61 percent on Wednesday.
    Transocean Ltd. (NYSE: RIG) shares fell 3.5 percent to $12 in pre-market trading after the company issued quarterly fleet status report.
    GoPro, Inc. (NASDAQ: GPRO) fell 3.2 percent to $4.90 in pre-market trading.
    Unilever PLC (NYSE: UL) fell 2.6 percent to $54.73 in pre-market

  • [By Shane Hupp]

    Church & Dwight (NYSE: CHD) and Unilever (NYSE:UL) are both large-cap consumer staples companies, but which is the better investment? We will contrast the two businesses based on the strength of their institutional ownership, risk, dividends, profitability, analyst recommendations, earnings and valuation.

  • [By Isaac Pino, CPA]

    Dollar Shave Club, bought by Unilever (NYSE:UL) in 2016, offers membership as low as $5. Again, the margins may be thin on the products — just like at Costco — but that’s made up by what hopefully becomes a longer, deeper relationship with the customer.

Hot High Tech Stocks To Watch Right Now

MTN Group Ltd. expects the listing of its Nigerian unit on the Lagos stock exchange to be done by the end of 2018, its CEO said, after suggesting in November that the process would be concluded by mid-year.

“We are progressing very well with the Nigerian listing and if market conditions are appropriate, we will conclude that by the end of the year,” Rob Shuter said Tuesday in an interview in Lagos. He declined to provide more details on the process.

MTN agreed to the Nigerian Stock Exchange initial public offering as part of the settlement of a $1 billion fine imposed by local regulators in 2015. Africa’s biggest wireless operator by sales incurred the penalty after missing a deadline to disconnect unregistered subscribers amid a security crackdown in the West African country. Nigeria is the largest of the company’s 22 markets across Africa and the Middle East.

MTN is planning to raise at least $500 million from the sale of shares, people familiar with the preparations for the listing said. The company could dispose of as much as 30 percent of its Lagos-based unit, the people, who asked not to be identified as the details aren’t public, said in February.

Hot High Tech Stocks To Watch Right Now: Inogen, Inc(INGN)

Advisors’ Opinion:

  • [By Michael A. Robinson]

    I put these rules in action for you in March 2015 when I recommendedInogen Inc.(Nasdaq: INGN)here in these pages.

    Inogen is pioneering the use of portable oxygen concentrators (POCs). And theGoleta, Calif.-based firm boasts breakthrough technology that has disrupted its entire sector.

Hot High Tech Stocks To Watch Right Now: Applied DNA Sciences Inc(APDN)

Advisors’ Opinion:

  • [By Max Byerly]

    These are some of the media headlines that may have effected Accern Sentiment’s rankings:

    Get Applied DNA Sciences alerts:

    Applied DNA Sciences’ (APDN) CEO James Hayward on Q2 2018 Results – Earnings Call Transcript (seekingalpha.com) Edited Transcript of APDN earnings conference call or presentation 3-May-18 8:30pm GMT (finance.yahoo.com) Applied DNA Sciences: Fiscal 2Q Earnings Snapshot (finance.yahoo.com) Applied DNA Sciences (APDN) Stock Rating Upgraded by ValuEngine (americanbankingnews.com) Applied DNA Reports Fiscal Second Quarter 2018 Financial Results (finance.yahoo.com)

    A number of research analysts have issued reports on the stock. Maxim Group set a $5.00 price target on shares of Applied DNA Sciences and gave the stock a “buy” rating in a report on Friday, April 6th. ValuEngine raised shares of Applied DNA Sciences from a “strong sell” rating to a “sell” rating in a report on Friday, February 2nd.

  • [By Shane Hupp]

    Ascent Capital Group (NASDAQ: ASCMA) and Applied DNA Sciences (NASDAQ:APDN) are both small-cap industrial products companies, but which is the superior stock? We will contrast the two businesses based on the strength of their analyst recommendations, valuation, dividends, risk, profitability, earnings and institutional ownership.

Hot High Tech Stocks To Watch Right Now: Vitality Biopharma (VBIO)

Advisors’ Opinion:

  • [By James E. Brumley]

    Investors who were looking to learn a little more about up-and-coming drug development company Vitality Biopharma Inc (OTCMKTS:VBIO) may want to mark December 8th on their calendar…. if they’re going to be in the Los Angeles area that day anyway. The company will be making a presentation that day, at the annual LD Micro Main Event. Interested and approved investors can attend the VBIO presentation by registering beforehand with LD Micro.

    Vitality Biopharma has found a way to make cannabinoid-based pharmaceuticals without the usual downside of cannabinoids. Namely, Vitality Biopharma’s version of cannabinoids are non-psychotropic, meaning larger, more effective dosing is possible without the ‘high’. It’s this little detail that takes cannabinoid medicine — already the most compelling frontier in the world of pharma — to the next level. There’s a reason some people think the cannabinoid market could be worth $20 billion by 2020.

    The idea was significantly advanced in early November. In eight of the nine states voters were asked about legalization of marijuana (for one reason or another), voters said yes….. four for recreational use, and four for medical use. In eight of those nine states, the measures passed. Marijuana is legal in more than half the United States now, and we’re en route to a decided majority in the foreseeable future.

    VBIO didn’t necessarily need a sweeping victory at the ballot box, but each time marijuana wins, it seems to advance the discussion of the power of cannabinoids as medicine.

    Investors will be able to learn more about Vitality Biopharma’s work in that arena on Thursday of this week. On that day — 8 AM PST / 11 AM EST — at the Luxe Sunset Boulevard Hotel in Los Angeles, CA. Robert Brooke, CEO of Vitality Biopharma, will be making a presentation as well as meeting with current and prospective investors.

    LD Micro was founded in 2006 with the sole purpose of being an independent resource in t

  • [By Phil Saunders]

    Vitality Biopharma, Inc. (OTCBB: VBIO) recent ascent as a strong small cap player in Cannabis pharma, is part of a boom in Cannabis-based pharmaceuticals making announcements about unique and innovative delivery systems being tested for such ailments as Epilepsy, Multiple Sclerosis, and Crohns disease. But it is important to understand how the industry is evolving in the United States and Canada and what that might mean when realizing valuation and the evolution of government policies which still vary from jurisdiction to jurisdiction, making access to Cannabis and the pricing model still a big question moving forward.

  • [By James E. Brumley]

    Are you an investor interested in learning more about Vitality Biopharma Inc (OTCMKTS:VBIO)? Or, are you looking to take your first look at VBIO? A SeeThruEquity research report posted in August not only has you covered, it underscores all of its hidden bullishness. The report also explains a very impressive target price for Vitality Biopharma shares. In short, the research outfit now believes the stock will see $2.00 per share sooner than later, based on its pipeline and potential market penetration. That’s 38% higher than its current value.

  • [By Matthew Briar]

    Back in September, Vitality Biopharma Inc (OTCMKTS:VBIO) CEO Robert Brooke officially announced his company would be entering the painkiller market, specifically taking aim at the development of an alternative to opioids. His specific words? “Opiates are one of the key classes of drugs we’re seeking to replace, or to make far less necessary, as our proprietary cannabosides could provide a potent alternative form of pain relief and help avoid, or greatly reduce, the use of opiates for the treatment of many conditions…”

  • [By James E. Brumley]

    In mid-September, Vitality Biopharma Inc (OTCMKTS:VBIO) announced it was going to take aim at the development of an alternative to opioids as a means of treating pain. At the time, there was little doubt that the company’s cannabinoid science was capable of doing so. What wasn’t clear to VBIO shareholders was exactly how that might happen…. meaning what sort of drug might Vitality Biopharma come up with.

    We got the first of what will likely be several answers to the question today. Per today’s press release, Vitality Biopharma intends to come up with a treatment for narcotic bowel syndrome, which is a severe form of (ironically enough) opiate-induced abdominal pain.

    As a refresher, Vitality Biopharma was the name we introduced to you back on August 8th, pointing out it had developed a whole new way of making cannabinoid-based medicines. Their versions offer all the upsides of cannabinoids, but without the psychotropic (“getting high’) effects, and without some of the common downsides associated with these pharmaceuticals… like mouth and skin lesions.

    There are even bigger advantages to Vitality Biopharma’s science, however. Namely, since these drugs are prodrugs and aren’t activated until in the body, they allow for targeted delivery to the GI tract (yet can also selectively target other body parts, even as far away from the GI tract as the brain). Perhaps more than anything though, these drugs are orally-administered by virtue of being highly soluble, making them easy to use.

    It’s this nuance that makes Vitality Biopharma’s recently-announced intention so interesting, and compelling.

    Studies have found that up to 81% of patients treated with opiates have functional bowel disorders, with more than half — 58% to be exact — of opiate users reporting chronic abdominal pain stemming from the use of their prescribed painkillers. Considering 200 million opioid prescriptions are filled every year in the United States alo

  • [By Jim Robertson]

    That’s why its worth pointing out that just yesterday, small cap cannabinoid prodrug pharmaceutical stock Vitality Biopharma, Inc. (OTCQB: VBIO) announced the appointment of Tracy Rockney, J.D. to the position of Senior Regulatory Advisor. In addition to being the Co-Founder & Chief Operating Officer of OneSource Regulatory, a regulatory consulting firm, Rockney was previously:

Hot High Tech Stocks To Watch Right Now: Randgold Resources Limited(GOLD)

Advisors’ Opinion:

  • [By Lisa Levin]

    Check out these big penny stock gainers and losers

    Losers
    MDC Partners Inc. (NASDAQ: MDCA) fell 23.4 percent to $5.25 in pre-market trading after a first-quarter earnings miss.
    Hudson Technologies Inc. (NASDAQ: HDSN) shares fell 15.1 percent to $3.48 in pre-market trading after the company reported downbeat Q1 earnings.
    Nuance Communications, Inc. (NASDAQ: NUAN) fell 14 percent to $13.15 in pre-market trading after the company posted downbeat Q2 earnings and lowered FY18 organic growth guidance.
    Myomo, Inc. (NYSE: MYO) fell 13.2 percent to $3.10 in pre-market trading after reporting downbeat quarterly results.
    Rowan Companies plc (NYSE: RDC) shares fell 10.7 percent to $14.13 in pre-market trading after climbing 8.50 percent on Wednesday.
    BT Group plc (NYSE: BT) fell 9 percent to $14.80 in pre-market trading after the company reported Q4 results and announced plans to cut 13,000 jobs over the next three years.
    Exelixis, Inc. (NASDAQ: EXEL) fell 8.3 percent to $19.90 in pre-market trading after the company disclosed that IMblaze370 Phase 3 pivotal trial of atezolizumab and cobimetinib in patients with heavily pretreated locally advanced or metastatic colorectal cancer did not meet primary endpoint.
    Infinera Corporation (NASDAQ: INFN) fell 8.2 percent to $10.80 in pre-market trading after reporting Q1 results.
    Synaptics, Incorporated (NASDAQ: SYNA) shares fell 7.4 percent to $43.00 in pre-market trading. Synaptics reported better-than-expected earnings for its third quarter, while sales missed estimates.
    Randgold Resources Limited (NASDAQ: GOLD) shares fell 7.4 percent to $76.23 in pre-market trading after reporting Q1 earnings.
    Integra LifeSciences Holdings Corporation (NASDAQ: IART) shares fell 7 percent to $59.36 in pre-market trading. Integra LifeSciences priced its 5.25 million share public offering of common stock at $58.50 per share.
    Array BioPharma Inc. (NASDAQ: ARRY) shares fell 6.9 percent to $12.75 in pre-m

  • [By Alex McGuire]

    This list shows the top-performing gold stocks this month, which we’ll be watching in September 2017. While these stocks posted gains in August, we still aren’t recommending them. Instead, we’re going to show you Money Morning Resource Specialist Peter Krauth’s pick for the best gold stock to buy this year…

    Top Gold Stock Share Price August 2017 Gain
    Sibanye Gold Ltd. (NYSE ADR: SBGL) $6.35 +22.9%
    Iamgold Corp. (NYSE: IAG) $6.49 +20%
    Alamos Gold Inc. (NYSE: AGI) $8.17 +15.1%
    Franco Nevada Corp. (NYSE: FNV) $81.20 +11.6%
    Hudbay Minerals Inc. (NYSE: HBM) $8.70 +11.5%
    Gold Fields Ltd. (NYSE ADR: GFI) $4.42 +10.9%
    Randgold Resources Ltd. (Nasdaq ADR: GOLD) $101.90 +9.6%
    Harmony Gold Mining Co. (NYSE ADR: HMY) $1.97 +8.8%
    Agnico Eagle Mines Ltd. (NYSE: AEM) $50.60 +8.4%
    Yamana Gold Inc. (NYSE: AUY) $2.81 +7.9%

    Life-Changing Profits: This investing strategy has racked up 30 triple-digit wins so far this year – and 46 in the last 12 months. To learn how to get in position for the next one, click here now…

  • [By Todd Campbell]

    If these reasons have you interested in adding gold mining stocks to your portfolio, a few top companies to consider are Barrick Gold (NYSE:ABX), Randgold Resources (NASDAQ:GOLD), Newmont Mining (NYSE:NEM), Freeport McMoran (NYSE:FCX) and Goldcorp (NYSE:GG). All five could benefit if gold prices rally, so let’s learn more about them.

Top Value Stocks To Own Right Now

Mid cap electronic manufacturing services (EMS) stock Flextronics International Ltd (NASDAQ: FLEX) reported Q1 2017 earnings after the market closed on Thursday with results missing Wall Street expectations and shares falling in afterhours/premarket trading. Net sales grew 2% to $6.0 billion and GAAP net income was approximately $125 millionversus net income of $106 million. The CEO commented:

“Our Sketch-to-Scale strategy remains firmly on track as reflected in our first quarter results which were within guidance ranges. While fiscal 2018 is an investment year, we continue to evolve our portfolio and enter and create new markets that will generate meaningful value and expand the Company’s total available market.”

A technical chart for Flextronics International shows shares mostly staying above a $16 support level:

Top Value Stocks To Own Right Now: Inogen, Inc(INGN)

Advisors’ Opinion:

  • [By Michael A. Robinson]

    I put these rules in action for you in March 2015 when I recommendedInogen Inc.(Nasdaq: INGN)here in these pages.

    Inogen is pioneering the use of portable oxygen concentrators (POCs). And theGoleta, Calif.-based firm boasts breakthrough technology that has disrupted its entire sector.

Top Value Stocks To Own Right Now: Newcastle Investment Corporation(NCT)

Advisors’ Opinion:

  • [By Jim Robertson]

    Today, our Under the Radar Moversnewsletter suggested shortingsmall cap debt and golf course REITNewcastle Investment Corp (NYSE: NCT):

    this isn’t apt to become a huge winner, but it’s a high-odds winner.

  • [By Lee Jackson]

    Newcastle Investment Corp. (NYSE: NCT) also had a director buying shares this past week. Wesley Edens picked up1 million shares of the stock at a price of $4.37. The total for the trade was posted at $4,370,000. The consensus price target for the stock is $4.50.The company invests in and manages real estate related and other investments. Its stock ended the weekat $4.31.

Top Value Stocks To Own Right Now: (SHF)

Advisors’ Opinion:

  • [By Money Morning Staff Reports]

    In March 2012, Schiff Nutrition International Inc. (NYSE: SHF) acquired the company for $150 million in cash.

    The product is still on the market today, found at most local drug stores. It is advertised now, however, as a nutritional supplement that does not, if taken alone, ward off viruses.

Top 5 Casino Stocks To Buy For 2019

Related CIG Mid-Afternoon Market Update: CytomX Therapeutics Climbs Following Bristol-Myers Squibb Partnership; Medgenics Shares Slide Mid-Day Market Update: Nektar Surges After Positive Results From NKTR-181 Study; Cerulean Pharma Shares Drop
Related PAM Mid-Morning Market Update: Markets Open Higher; Groupe Casino Offers To Buy Cnova Earnings Scheduled For November 15, 2016

Toward the end of trading Friday, the Dow traded down 0.24 percent to 20,606.58 while the NASDAQ rose 0.14 percent to 5,825.95. The S&P also fell, dropping 0.09 percent to 2,343.87.

Leading and Lagging Sectors

Friday afternoon, the utilities sector proved to be a source of strength for the market. Leading the sector was strength from Cia Energetica de Minas Gerais CEMIG-ADR (NYSE: CIG) and Pampa Energia S.A. (ADR) (NYSE: PAM).

In trading on Friday, basic materials shares fell 0.73 percent. Meanwhile, top losers in the sector included US Concrete Inc (NASDAQ: USCR), down 8 percent, and Seabridge Gold, Inc. (USA) (NYSE: SA), down 5 percent.

Top 5 Casino Stocks To Buy For 2019: Ono Pharmaceutical Co., Ltd. (OPHLF)

Advisors’ Opinion:

  • [By SEEKINGALPHA.COM]

    Merck could achieve a consistent advantage versus BMS in treatment of 1L NSCLC. There is a precise crossroad that will determine the future of these two companies in this field: the question of whether or not Keytruda will be approved in May. Both the market and investors believe that it will indeed gain approval and BMS’s stock is already paying for that. In the short term, the repercussions will be the contractions in the sales of Opdivo in 2L and a bigger obstacle for Opdivo+Yervoy in 1L. But the BMS’s combo can catch up, thanks to a bigger efficacy, as I will explain in a future article. Meanwhile, a recent trial established that Merck has to pay BMS $625M plus royalties, as it infringed BMS’s intellectual property related to the use of anti-PD1 antibodies. The royalties will be 6.5% for sales between January 2017 and the end of 2023, followed by a 2.5% rate for the period from January 2024 to the end of 2026. Bristol-Myers Squibb will share the money by giving a quarter of the amount to the Japanese Ono Pharmaceutical (OTC:OPHLF), the company which had discovered Opdivo.

Top 5 Casino Stocks To Buy For 2019: CytRx Corporation(CYTR)

Advisors’ Opinion:

  • [By Roberto Pedone]

    Another under-$10 biotechnology player that’s starting to trend within range of triggering a major breakout trade is CytRx (CYTR), which has an oncology pipeline that includes two programs in clinical development for cancer indications: aldoxorubicin and tamibarotene. This stock has been moving to the upside during the last three months, with shares up by 21%.

    If you take a look at the chart for CytRx, you’ll notice that this stock has been trending sideways inside of a consolidation chart pattern for the last two months, with shares moving between $2.27 on the downside and $2.68 on the upside. That consolidation pattern has occurred right above this stock’s 50-day and 200-day moving averages. Shares of CYTR have now started to break out above some near-term overhead resistance at $2.49 a share. That move is quickly pushing CYTR within range of triggering an even bigger breakout trade above the upper-end of its recent sideways trading chart pattern.

    Market players should now look for long-biased trades in CYTR if it manages to break out above some near-term overhead resistance levels at $2.68 to $2.80 a share with high volume. Look for a sustained move or close above those levels with volume that registers near or above its three-month average action of 154,838 shares. If that breakout triggers soon, then CYTR will set up to re-test or possibly take out its next major overhead resistance levels at $3.20 to $4 a share.

    Traders can look to buy CYTR off any weakness to anticipate that breakout and simply use a stop that sits right below its 200-day at $2.33 a share or below more support at $2.27 a share. One can also buy CYTR off strength once it clears those breakout levels with volume and then simply use a stop that sits a comfortable percentage from your entry point.

Top 5 Casino Stocks To Buy For 2019: Inogen, Inc(INGN)

Advisors’ Opinion:

  • [By Michael A. Robinson]

    I put these rules in action for you in March 2015 when I recommendedInogen Inc.(Nasdaq: INGN)here in these pages.

    Inogen is pioneering the use of portable oxygen concentrators (POCs). And theGoleta, Calif.-based firm boasts breakthrough technology that has disrupted its entire sector.

Top 5 Casino Stocks To Buy For 2019: Controladora Vuela Compania de Aviacion, S.A.B. de C.V.(VLRS)

Advisors’ Opinion:

  • [By Adam Levine-Weinberg]

    In addition to Southwest, Alaska Air, and JetBlue, Mexican ultra-low cost carriers (ULCCs)Volaris (NYSE:VLRS) and VivaAerobus requested numerous slots in Mexico City. However, the DOT showed a strong preference for the U.S. carriers’ requests. In fact, Southwest Airlines, Alaska Air, and JetBlue Airways each received all of the slots they wanted.

Top 5 Casino Stocks To Buy For 2019: Lithium X Energy Corp. (LIXXF)

Advisors’ Opinion:

  • [By SEEKINGALPHA.COM]

    The other producing lithium miners, and soon to be producers. I have discussed these previously in detail here, here and here. Needless to say, the top 3 producers are non-pure plays (SQM (NYSE:SQM), Albemarle (NYSE:ALB), and FMC Corp. (NYSE:FMC)). The top pure play currently producing miners are Orocobre (ASX:ORE) (OTCPK:OROCF), Tianqi Lithium (SHE:002466), Jiangxi Ganfeng Lithium, Galaxy Resources, Mineral Resources [ASX:MIN] (OTC:MALRF), and Neometals [ASX:NMT] (OTC:RRSSF). The near-term producers include Altura Mining [ASX:AJM] (OTCPK:ALTAF), Pilbara Minerals (ASX:PLS) (OTC:PILBF), Kidman Resources (ASX:KDR), Critical Elements, Nemaska Lithium (OTCQX:NMKEF) [TSX:NMX], Lithium Americas (OTCQX:LACDF) [TSX:LAC], Lithium X (OTCQX:LIXXF) (TSXV:LIX), Neo Lithium, and Bacanora Minerals (OTC:BCRMF) [TSXV:BCN], Advantage Lithium (OTCQB:AVLIF) [AAL], European Metals (OTCPK:MNTCF, ASX:EMH, AIM:EMH) and Pure Energy (OTCQB:PEMIF) [PE].

  • [By Tom Bishop]

    Lithium X Energy NPV (LIXXF) owns 50% of the Sal de los Angeles lithium brine project in the prolific “Lithium Triangle” in mining friendly Salta province, Argentina.

Top 10 Blue Chip Stocks To Invest In Right Now

&l;p&g;&l;img class=&q;dam-image shutterstock size-large wp-image-637816771&q; src=&q;https://specials-images.forbesimg.com/dam/imageserve/637816771/960×0.jpg?fit=scale&q; data-height=&q;640&q; data-width=&q;960&q;&g; Shutterstock

With earnings season in the rear-view and the end of the first quarter looming, you&a;rsquo;re probably asking yourself &l;i&g;one thing&l;/i&g; right now&a;hellip;

&a;hellip; just how good is the stock market?

I&a;rsquo;ll give you the answer (which I think you&a;rsquo;ll like) in a moment.

Then I&a;rsquo;ll show you 2 funds whose portfolios are packed with familiar stocks, including &l;b&g;Apple&l;/b&g;. Both funds are poised for strong gains in 2018 while handing you fat cash payouts up to 8.8%!

&l;b&g;Finding Bargains in a Surprising Place&l;/b&g;

First, if you&a;rsquo;re like most folks, you might feel queasy about &l;i&g;any&l;/i&g; stocks&a;mdash;including &a;ldquo;reliable&a;rdquo; blue chips&a;mdash;after the stomach-churning drops we suffered in February.

Top 10 Blue Chip Stocks To Invest In Right Now: Dupont Fabros Technology, Inc.(DFT)

Advisors’ Opinion:

  • [By Lisa Levin]

    DuPont Fabros Technology, Inc. (NYSE: DFT) shares shot up 10 percent to $61.07. Digital Realty Trust, Inc. (NYSE: DLR) announced plans to merge with DuPont Fabros.

Top 10 Blue Chip Stocks To Invest In Right Now: Tofutti Brands Inc.(TOF)

Advisors’ Opinion:

  • [By Peter Graham]

    A long term performance chart for Dean Foods Co shows a decent long term return as small caps Lifeway Foods, Inc (NASDAQ: LWAY) and non-dairy desert stock Tofutti Brands Inc (NYSEMKT: TOF) have come up even for investors while mid cap dairy and organics stock WhiteWave Foods Co (NYSE: WWAV) has been an outperformer (Note: Wehad WhiteWave Foods Coin our SmallCap Network Elite Opportunity (SCN EO) portfolio back in October 2014 when our SCN EO newslettersaid that the stock could be an excellent acquisition candidate for a competing mega cap food producer to acquire):

  • [By Peter Graham]

    A long term performance chart for Dean Foods Co shows a positive but not spectacular long term return as small cap Lifeway Foods, Inc (NASDAQ: LWAY) has been more volatile and non-dairy desert stock Tofutti Brands Inc (NYSEMKT: TOF) has given a moderately positive performance:

Top 10 Blue Chip Stocks To Invest In Right Now: Inogen, Inc(INGN)

Advisors’ Opinion:

  • [By Michael A. Robinson]

    I put these rules in action for you in March 2015 when I recommendedInogen Inc.(Nasdaq: INGN)here in these pages.

    Inogen is pioneering the use of portable oxygen concentrators (POCs). And theGoleta, Calif.-based firm boasts breakthrough technology that has disrupted its entire sector.

Top 10 Blue Chip Stocks To Invest In Right Now: (SHF)

Advisors’ Opinion:

  • [By Money Morning Staff Reports]

    In March 2012, Schiff Nutrition International Inc. (NYSE: SHF) acquired the company for $150 million in cash.

    The product is still on the market today, found at most local drug stores. It is advertised now, however, as a nutritional supplement that does not, if taken alone, ward off viruses.

Top 10 Blue Chip Stocks To Invest In Right Now: Minerva Neurosciences, Inc(NERV)

Advisors’ Opinion:

  • [By Lisa Levin]

    Minerva Neurosciences Inc (NASDAQ: NERV) shares shot up 194 percent to $10.39 after the company revealed positive top line results from a prospective Phase IIb, 12-week, randomized, double-blind, placebo-controlled parallel clinical study evaluating the efficacy, safety and tolerability of MIN-101 in patients with negative symptoms of schizophrenia.

Top 10 Blue Chip Stocks To Invest In Right Now: iShares Core S&P Mid-Cap (IJH)

Advisors’ Opinion:

  • [By WWW.GURUFOCUS.COM]

    For the details of Lubar & Co., Inc’s stock buys and sells, go to http://www.gurufocus.com/StockBuy.php?GuruName=Lubar+%26+Co.%2C+Inc

    These are the top 5 holdings of Lubar & Co., IncEnLink Midstream LLC (ENLC) – 1,882,007 shares, 37.97% of the total portfolio. Shares added by 0.40%Hallador Energy Co (HNRG) – 2,788,685 shares, 23.23% of the total portfolio. Vanguard Value ETF – DNQ (VTV) – 77,126 shares, 7.65% of the total portfolio. iShares Core S&P Mid-Cap (IJH) – 38,400 shares, 6.84% of the total portfolio. New PositionVanguard Mid-Cap Value ETF – DNQ (VOE) – 61,550 shares, 6.52% of the tota

Top 10 Blue Chip Stocks To Invest In Right Now: TAL International Group Inc.(TAL)

Advisors’ Opinion:

  • [By Craig Jones]

    Instead of buying TAL Education Group (ADR) (NYSE: TAL), Cramer would buy Alibaba Group Holding Ltd (NYSE: BABA).

    Cramer thinks Burlington Stores Inc (NYSE: BURL) is going to have a good quarter, because Ross Stores, Inc. (NASDAQ: ROST) posted a good one, and they have similar business models.

Top 10 Blue Chip Stocks To Invest In Right Now: EQT Corporation(EQT)

Advisors’ Opinion:

  • [By Chris Lange]

    The S&P 500 stock posting the largest daily percentage loss ahead of the close Thursday was EQT Corp. (NYSE: EQT) which traded down over 5% at $49.72. The stocks 52-week range is $43.70 to $67.84. Volume was 7.6 million compared to the daily average volume of nearly 4 million.

  • [By Paul Ausick]

    EQT Corp. (NYSE: EQT) is rated Hold and the price target was lowered to $69. The 2017 EPS estimate was also lowered, from $1.54 to $0.68, and the 2018 estimate was raised from $1.26 to $1.65. Shares closed at $59.29 on Friday, in a 52-week range of $56.38 to $80.61. The consensus 12-month price target is $83.00.

  • [By elliottwave]

    EQT Corporation (NYSE: EQT) failed to make new highs and it’s now doing a double three correction from June 2016 peak which already reached the extreme area at $85.17 with enough number of swings to end that cycle. However in the short term, the stock can still extend toward the equal legs area $50.67 from December 2016 peak before buyers show up to resume the rally or bounce in 3 waves at least while holding above $47.10 low

    Exxon Mobil Corporation (NYSE: XOM) is still correcting an older cycle from August 2015 doing a flat structure from July 2016 peak and currently at the last leg of wave (C) that could ideally reach the equal legs area $79.88 – $76.72 before the stock start bouncing in 3 waves at least. The flat structure is tricky because it can always extend but XOM needs to hold above $66.55 to continue its multi-year bullish trend.

    Recap :

  • [By Chris Lange]

    The S&P 500 stock posting the largest daily percentage loss ahead of the close Monday was EQT Corp. (NYSE: EQT) which traded down about 9% at $53.50. The stocks 52-week range is $52.67 to $80.61. Volume was over 21.5 million versus the daily average of 2.2 million shares.

  • [By Chris Lange]

    The stock posting the largest daily percentage gain in the S&P 500 ahead of the close Thursday was EQT Corp. (NYSE: EQT) which rose about 10% to $53.35. The stocks 52-week range is $43.70 to $67.84. Volume was nearly 11 million compared to the daily average volume of 3.6 million.

  • [By Elizabeth Balboa]

    Traders circulated chatter that activist firm Jana Partners took a 5-percent stake in EQT Corporation (NYSE: EQT) with the intention of tanking its pending, $6.7 billion purchase of Rice Energy Inc (NYSE: RICE).

Top 10 Blue Chip Stocks To Invest In Right Now: Care.com, Inc.(CRCM)

Advisors’ Opinion:

  • [By Lisa Levin]

    Shares of Care.com Inc (NYSE: CRCM) got a boost, shooting up 16 percent to $11.01 after the company reported upbeat quarterly results.

    MaxPoint Interactive Inc (NASDAQ: MXPT) shares were also up, gaining 19 percent to $5.44. MaxPoint Interactive reported Q4 earnings of $0.59 per share on revenue of $46.3 million.

Top 10 Blue Chip Stocks To Invest In Right Now: Athene Holding Ltd. (ATH)

Advisors’ Opinion:

  • [By Lisa Levin]

    Breaking news

    Edwards Lifesciences Corp (NYSE: EW) announced plans to buy Valtech Cardio for $340 million in cash and stock. The company also announced a $1 billion buyback plan.
    Epizyme Inc (NASDAQ: EPZM) disclosed that it has received Fast Track designation for tazemetostat.
    Athene Holding Ltd. (NYSE: ATH) reported that it has priced its 23.8 million share IPO between $38 per share and $42 per share.
    Lannett Company, Inc. (NYSE: LCI) reported the approval for its Metaxalone Tablets USP, 800 mg.